Ризедронат Тева 35 мг

Ülke: İsrail

Dil: Rusça

Kaynak: Ministry of Health

Aktif bileşen:

RISEDRONIC ACID AS SODIUM 35 MG

Mevcut itibaren:

ABIC MARKETING LTD

ATC kodu:

M05BA07

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Terapötik grubu:

RISEDRONIC ACID

Terapötik endikasyonlar:

Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. Treatment of osteoporosis in men at high risk of fracture.

Yetkilendirme tarihi:

2011-10-01